Kasmirski Julia Adriana, Allahwasaya Ashba, Wu Christopher, Song Zhixing, Akhund Ramsha, Balachandra Sanjana, McLeod M Chandler, Gillis Andrea, Fazendin Jessica, Lindeman Brenessa, Chen Herbert
University of Alabama at Birmingham, Birmingham, AL, United States.
Ann Surg. 2025 Jan 15. doi: 10.1097/SLA.0000000000006631.
To assess the impact of parathyroid gland autotransplantation on the restoration of parathyroid function in patients who are hypoparathyroid after thyroidectomy.
Hypoparathyroidism post-thyroidectomy arises when all parathyroid glands are devascularized or injured. Autotransplantation of compromised parathyroids aims to preserve their function and prevent permanent hypoparathyroidism. Despite routine use, comprehensive evidence on the efficacy of parathyroid autotransplantation remains limited.
A retrospective analysis was conducted on 549 patients who underwent total or completion thyroidectomy from December 2015 to June 2023. Surgical outcomes of patients with and without parathyroid autotransplantation were compared. A subgroup analysis included patients with post-anesthesia care unit (PACU) parathyroid hormone (PTH) levels below 10 units. Statistical analyses included the Chi-squared test and multivariable analysis.
Of the 549 patients, 152 (27.7%) had parathyroid autotransplantation and 397 (72.3%) did not. The groups were similar in demographics and underlying thyroid etiologies. No significant difference was found in intraoperative parathyroid identification rates (P=0.25). Postoperatively, autotransplanted patients had a higher incidence of transient symptomatic hypocalcemia at 2 weeks (38.0% vs. 19.3%, P<0.001). Multivariable regression showed a higher frequency of postoperative transient hypocalcemia with autotransplantation (IRR=1.90, 95% CI: 1.42-2.54, P<0.001). Among patients with PACU PTH<10 units, recovery rates of parathyroid function were similar between treatment groups (82.2% vs. 82.5%, P=0.46). Long-term follow-up showed comparable low incidence of parathyroid insufficiency in both groups (5.3% vs. 3.8%, P=0.46).
Parathyroid autotransplantation does not enhance recovery in hypoparathyroid patient's post-thyroidectomy and does not significantly alter outcomes among patients with PACU PTH<10 .
评估甲状旁腺自体移植对甲状腺切除术后甲状旁腺功能减退患者甲状旁腺功能恢复的影响。
当所有甲状旁腺的血供被阻断或受到损伤时,会发生甲状腺切除术后甲状旁腺功能减退。对受损甲状旁腺进行自体移植旨在保留其功能并预防永久性甲状旁腺功能减退。尽管甲状旁腺自体移植已常规使用,但关于其疗效的全面证据仍然有限。
对2015年12月至2023年6月期间接受全甲状腺切除术或甲状腺次全切除术的549例患者进行回顾性分析。比较了接受和未接受甲状旁腺自体移植患者的手术结果。亚组分析纳入了麻醉后监护病房(PACU)甲状旁腺激素(PTH)水平低于10单位的患者。统计分析包括卡方检验和多变量分析。
549例患者中,152例(27.7%)接受了甲状旁腺自体移植,397例(72.3%)未接受。两组在人口统计学特征和潜在甲状腺病因方面相似。术中甲状旁腺识别率无显著差异(P = 0.25)。术后,接受自体移植的患者在术后2周时短暂性症状性低钙血症的发生率较高(38.0%对19.3%,P < 0.001)。多变量回归显示自体移植术后短暂性低钙血症的发生率更高(风险比=1.90,95%置信区间:1.42 - 2.54,P < 0.001)。在PACU PTH < 10单位的患者中,治疗组之间甲状旁腺功能的恢复率相似(82.2%对82.5%,P = 0.46)。长期随访显示两组甲状旁腺功能不全的发生率相当低(5.3%对3.8%,P = 0.46)。
甲状旁腺自体移植并不能促进甲状腺切除术后甲状旁腺功能减退患者的恢复,并且在PACU PTH < 10的患者中不会显著改变预后。